JENNIFER TITCHNELL: Open Payments
NPI 1609150226 · NEW WINDSOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 31 payments from 8 companies in 2025. Trend: 2023 $428 · 2024 $1,331 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $156 |
| GlaxoSmithKline, LLC. | 6 | $118 |
| Lilly USA, LLC | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: TRELEGY ELLIPTA, MOUNJARO, BREZTRI, Auvelity, Wegovy, Ozempic, Rybelsus, JARDIANCE.
Industry payments across NY — which companies pay providers there.
